Bayer agrees to settle legacy litigation and Roundup claims for over $10bn

German pharmaceutical firm Bayer has agreed to pay between $10.1bn and $10.9bn to settle three major litigations it inherited when buying Monsanto in 2018, including a proposal to resolve the majority of US claims against weedkiller Roundup for causing cancer. The payment, which needs court approval, covers about 75% – or 125,000 – of Monsanto’s Roundup weedkiller litigation claims, and…

Please register or login to view the full post